T1	PROC 1277 1300	consumo de L. plantarum
T2	CHEM 71 87	inmunoglobulinas
#1	AnnotatorNotes T2	C0021027; Immunoglobulins; Amino Acid, Peptide, or Protein · Immunologic Factor
T3	PROC 96 126	vacunación contra la influenza
#2	AnnotatorNotes T3	C0042200; Influenza vaccination; Therapeutic or Preventive Procedure
T4	DISO 117 126	influenza
#3	AnnotatorNotes T4	C0021400; Influenza; Disease or Syndrome
T5	PROC 491 546	diseño aleatorizado, doble ciego controlado por placebo
#4	AnnotatorNotes T5	C0599724; placebo controlled study; Research Activity · Intellectual Product + C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T6	PROC 187 217	vacunación contra la influenza
#5	AnnotatorNotes T6	C0042200; Influenza vaccination; Therapeutic or Preventive Procedure
T7	DISO 208 217	influenza
#6	AnnotatorNotes T7	C0021400; Influenza; Disease or Syndrome
T8	CHEM 1403 1418	anticuerpos IgA
T9	CHEM 377 403	vacuna contra la influenza
#7	AnnotatorNotes T9	C0021403; Influenza virus vaccine; Pharmacologic Substance · Immunologic Factor
T10	PROC 779 801	consumo del probiótico
#8	AnnotatorNotes T10	C2242626; Probiotic therapy; Therapeutic or Preventive Procedure
T11	PROC 571 580	vacunados
#9	AnnotatorNotes T11	C0042196; Vaccination; Therapeutic or Preventive Procedure
T12	DISO 614 623	influenza
#10	AnnotatorNotes T12	C0021400; Influenza; Disease or Syndrome
T13	PROC 754 764	vacunación
#11	AnnotatorNotes T13	C0042196; Vaccination; Therapeutic or Preventive Procedure
T14	PROC 849 859	vacunación
#12	AnnotatorNotes T14	C0042196; Vaccination; Therapeutic or Preventive Procedure
T15	PROC 884 911	distribuidos aleatoriamente
#13	AnnotatorNotes T15	C0034656; Randomization; Research Activity
T16	PROC 1218 1243	consumieron el probiótico
T17	PROC 1349 1376	vacunación contra influenza
#14	AnnotatorNotes T17	C0042200; Influenza vaccination; Therapeutic or Preventive Procedure
T18	PROC 1392 1418	niveles de anticuerpos IgA
T19	PROC 1421 1424	IgG
#15	AnnotatorNotes T19	C0202087; Immunoglobulin G measurement; Laboratory Procedure
T20	DISO 1447 1456	influenza
#16	AnnotatorNotes T20	C0021400; Influenza; Disease or Syndrome
T21	CHEM 1529 1544	anticuerpos IgM
T22	DISO 1567 1576	influenza
#17	AnnotatorNotes T22	C0021400; Influenza; Disease or Syndrome
T23	CHEM 1721 1747	vacuna contra la influenza
#18	AnnotatorNotes T23	C0021403; Influenza virus vaccine; Pharmacologic Substance · Immunologic Factor
T24	DISO 394 403	influenza
#19	AnnotatorNotes T24	C0021400; Influenza; Disease or Syndrome
T25	CHEM 589 623	vacuna trivalente contra influenza
#20	AnnotatorNotes T25	C0770694; trivalent influenza vaccine; Organic Chemical · Pharmacologic Substance · Immunologic Factor
T26	PROC 1145 1152	placebo
#21	AnnotatorNotes T26	C0032042; Placebos; Therapeutic or Preventive Procedure
T27	DISO 1367 1376	influenza
#22	AnnotatorNotes T27	C0021400; Influenza; Disease or Syndrome
T28	PROC 1518 1544	niveles de anticuerpos IgM
T29	DISO 1738 1747	influenza
#23	AnnotatorNotes T29	C0021400; Influenza; Disease or Syndrome
T30	LIVB 1 24	Lactobacillus plantarum
#24	AnnotatorNotes T30	C0317608; Lactobacillus plantarum; Bacterium
T31	LIVB 130 138	ancianos
#25	AnnotatorNotes T31	C0001792; Elderly (population group); Population Group
T32	LIVB 230 238	ancianos
#26	AnnotatorNotes T32	C0001792; Elderly (population group); Population Group
T33	LIVB 305 328	Lactobacillus plantarum
#27	AnnotatorNotes T33	C0317608; Lactobacillus plantarum; Bacterium
T34	LIVB 407 415	ancianos
#28	AnnotatorNotes T34	C0001792; Elderly (population group); Population Group
T35	LIVB 430 458	ancianos institucionalizados
#29	AnnotatorNotes T35	C0001792; Elderly (population group); Population Group + C0376326; Institutionalized Persons; Patient or Disabled Group
T36	Age 460 470	65-85 años
T37	LIVB 791 801	probiótico
#30	AnnotatorNotes T37	C0525033; Probiotics; Bacterium
T38	Duration 809 834	entre tres y cuatro meses
T42	LIVB 1233 1243	probiótico
#31	AnnotatorNotes T42	C0525033; Probiotics; Bacterium
T43	Duration 1252 1259	3 meses
T44	Duration 1324 1334	tres meses
T46	LIVB 1751 1759	ancianos
#32	AnnotatorNotes T46	C0001792; Elderly (population group); Population Group
T47	LIVB 552 563	voluntarios
#33	AnnotatorNotes T47	C0020155; Human Volunteers; Population Group
T48	LIVB 1204 1217	participantes
#34	AnnotatorNotes T48	C4554048; Study Participant; Population Group
T49	Date 765 769	2006
T50	Date 770 774	2007
T51	LIVB 865 876	voluntarios
#35	AnnotatorNotes T51	C0020155; Human Volunteers; Population Group
T52	Dose 948 957	5*109 ufc
T53	Frequency 957 961	/día
T54	LIVB 965 977	L. plantarum
#36	AnnotatorNotes T54	C0317608; Lactobacillus plantarum; Bacterium
T39	Dose 1051 1060	5*108 ufc
T55	Frequency 1060 1064	/día
T56	LIVB 1068 1080	L. plantarum
#37	AnnotatorNotes T56	C0317608; Lactobacillus plantarum; Bacterium
T40	LIVB 1288 1300	L. plantarum
#38	AnnotatorNotes T40	C0317608; Lactobacillus plantarum; Bacterium
T41	LIVB 1606 1618	L. plantarum
#39	AnnotatorNotes T41	C0317608; Lactobacillus plantarum; Bacterium
T45	PHYS 1644 1668	efecto inmunoestimulador
#40	AnnotatorNotes T45	C2267003; Increased Immunologic Activity; Physiologic Function
T57	LIVB 296 301	cepas
#41	AnnotatorNotes T57	C1518614; Organism Strain; Organism
T58	LIVB 1597 1602	cepas
#42	AnnotatorNotes T58	C1518614; Organism Strain; Organism
T59	PROC 439 458	institucionalizados
#43	AnnotatorNotes T59	C0021629; Institutionalization; Health Care Activity
A1	Population_data T31 Age
A2	Population_data T32 Age
A3	Population_data T34 Age
A4	Population_data T35 Age
A5	Population_data T46 Age
T60	Spec_cue 1671 1678	podrían
T61	Observation 1695 1715	mejorar la respuesta
A6	Assertion T61 Speculated
T62	Quantifier_or_Qualifier 25 33	CECT7315
T63	Quantifier_or_Qualifier 36 44	CECT7316
R1	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T62	
R2	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T63	
T64	PHYS 45 87	estimula la producción de inmunoglobulinas
#44	AnnotatorNotes T64	C2253717; stimulation of immunoglobulin production; Cell Function
R3	After Arg1:T64 Arg2:T3	
R4	Causes Arg1:T30 Arg2:T64	
R5	Used_for Arg1:T2 Arg2:T64	
R6	Experiences Arg1:T31 Arg2:T3	
R7	Experiences Arg1:T31 Arg2:T64	
R8	Experiences Arg1:T32 Arg2:T6	
T65	Quantifier_or_Qualifier 329 343	CECT 7315/7316
R9	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T65	
T66	PHYS 349 371	estimular la respuesta
#45	AnnotatorNotes T66	C2255932; stimulation of immune response; Organism Function
R10	Causes Arg1:T33 Arg2:T66	
R12	Experiences Arg1:T34 Arg2:T9	
R13	Experiences Arg1:T34 Arg2:T66	
R14	Experiences Arg1:T34 Arg2:T6	
R15	Experiences Arg1:T32 Arg2:T66	
R16	Experiences Arg1:T32 Arg2:T9	
R17	Experiences Arg1:T35 Arg2:T59	
R18	Has_Age Arg1:T35 Arg2:T36	
R19	Experiences Arg1:T47 Arg2:T11	
R20	Used_for Arg1:T25 Arg2:T11	
R21	Experiences Arg1:T47 Arg2:T13	
R22	Used_for Arg1:T25 Arg2:T13	
R23	Overlap Arg1:T13 Arg2:T49	
R24	Overlap Arg1:T13 Arg2:T50	
R25	Overlap Arg1:T11 Arg2:T49	
R26	Overlap Arg1:T11 Arg2:T50	
R27	Used_for Arg1:T37 Arg2:T10	
R28	Has_Duration_or_Interval Arg1:T10 Arg2:T38	
R29	After Arg1:T10 Arg2:T14	
R30	Has_Frequency Arg1:T54 Arg2:T53	
R31	Before Arg1:T15 Arg2:T54	
R32	Has_Dose_or_Strength Arg1:T54 Arg2:T52	
T67	Quantifier_or_Qualifier 978 992	CECT 7315/7316
R33	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T67	
T68	Food 1173 1188	leche desnatada
#46	AnnotatorNotes T68	C0349375; skim milk; Food
T69	Form 1020 1028	en polvo
#47	AnnotatorNotes T69	C0032861; Powder dose form; Biomedical or Dental Material
T70	Food 1004 1019	leche desnatada
#48	AnnotatorNotes T70	C0349375; skim milk; Food
R34	Has_Drug_Form Arg1:T70 Arg2:T69	
T71	Form 1189 1197	en polvo
#49	AnnotatorNotes T71	C0032861; Powder dose form; Biomedical or Dental Material
R35	Has_Drug_Form Arg1:T68 Arg2:T71	
T72	Form 1123 1131	en polvo
#50	AnnotatorNotes T72	C0032861; Powder dose form; Biomedical or Dental Material
T73	Food 1107 1122	leche desnatada
#51	AnnotatorNotes T73	C0349375; skim milk; Food
R36	Has_Drug_Form Arg1:T73 Arg2:T72	
R37	Combined_with Arg1:T54 Arg2:T70	
T74	Result_or_Value 996 1000	20 g
R38	Has_Result_or_Value Arg1:T70 Arg2:T74	
T75	Result_or_Value 1099 1103	20 g
R39	Has_Result_or_Value Arg1:T73 Arg2:T75	
T76	Result_or_Value 1165 1169	20 g
R40	Has_Result_or_Value Arg1:T68 Arg2:T76	
R41	Used_for Arg1:T68 Arg2:T26	
T77	Quantifier_or_Qualifier 1081 1095	CECT 7315/7316
R42	Has_Quantifier_or_Qualifier Arg1:T56 Arg2:T77	
R43	Combined_with Arg1:T56 Arg2:T73	
R44	Has_Dose_or_Strength Arg1:T56 Arg2:T39	
R45	Has_Frequency Arg1:T56 Arg2:T55	
R46	Before Arg1:T15 Arg2:T26	
R47	Before Arg1:T15 Arg2:T56	
R48	Experiences Arg1:T48 Arg2:T16	
R49	Used_for Arg1:T42 Arg2:T16	
R50	Has_Duration_or_Interval Arg1:T16 Arg2:T43	
R51	Used_for Arg1:T40 Arg2:T1	
T78	Quantifier_or_Qualifier 1301 1315	CECT 7315/7316
R53	Has_Duration_or_Interval Arg1:T1 Arg2:T44	
R52	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T78	
R54	After Arg1:T1 Arg2:T17	
T79	Observation 1377 1418	incrementó los niveles de anticuerpos IgA
#52	AnnotatorNotes T79	C0239984; Increased circulating IgA level; Finding
R55	Causes Arg1:T1 Arg2:T79	
T80	Observation 1377 1414;1421 1424	incrementó los niveles de anticuerpos IgG
#53	AnnotatorNotes T80	C1858977; Increased circulating IgG level; Finding
R56	Causes Arg1:T1 Arg2:T80	
T81	Observation 1500 1544	incremento en los niveles de anticuerpos IgM
#54	AnnotatorNotes T81	C0239990; Immunoglobulin M increased; Finding | C1839972; Increased circulating IgM level; Finding
T82	Quantifier_or_Qualifier 1619 1633	CECT 7315/7316
R57	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T82	
R58	Causes Arg1:T41 Arg2:T45	
R59	Before Arg1:T41 Arg2:T61	
R60	Speculation Arg1:T60 Arg2:T61	
R61	Experiences Arg1:T46 Arg2:T23	
R62	Causes Arg1:T23 Arg2:T61	
R63	Experiences Arg1:T46 Arg2:T45	
R64	Experiences Arg1:T46 Arg2:T61	
R11	Before Arg1:T9 Arg2:T66	
#55	AnnotatorNotes T21	C0020861; Immunoglobulin M; Amino Acid, Peptide, or Protein · Immunologic Factor
#56	AnnotatorNotes T8	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
#57	AnnotatorNotes T18	C0202097; Anti-IgA assay; Laboratory Procedure
A7	Experiencer T31 Patient
A8	Experiencer T32 Patient
A9	Experiencer T34 Patient
A10	Experiencer T35 Patient
A11	Experiencer T47 Patient
A12	Experiencer T51 Patient
A13	Experiencer T48 Patient
A14	Experiencer T46 Patient
R65	Has_Result_or_Value Arg1:T19 Arg2:T80	
R66	Has_Result_or_Value Arg1:T18 Arg2:T79	
R67	Has_Result_or_Value Arg1:T28 Arg2:T81	
